For research use only
| Cat No. | ABC-TC3490 |
| Product Type | Vascular Cells |
| Cell Type | Fibroblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aorta |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Fibroblasts are mesenchymal cells which derived from the embryonic mesoderm.
Human Aortic Adventitia Fibroblasts are primary cells isolated from the tunica externa of human ascending or descending aorta. Following primary culture, these cells are cryopreserved. These cells exhibit a characteristic spindle-shaped morphology and grow as adherent monolayers. These cells are widely utilized to investigate the role of fibroblasts in aortic diseases, as they play critical roles in vascular remodeling through collagen/elastin synthesis and cytokine secretion (e.g., TGF-β, IL-6). Their pathological activation contributes to fibrosis in aortic adventitia, aortic aneurysms, atherosclerosis progression, and vascular stiffening in hypertension. Human Aortic Adventitia Fibroblasts express fibroblast markers vimentin and collagen I. To preserve optimal performance, repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Aortic Adventitia Fibroblasts, Aortic Adventitial Fibroblasts Human, HAAFs, Adventitial Fibroblasts Aorta, Human Aorta Adventitia Cells |
| Species | Human |
| Cat.No | ABC-TC3490 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aorta |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Vascular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Aortic Adventitia Fibroblasts serve as a critical in vitro model to study vascular remodeling mechanisms typically in aortic aneurysms and hypertension-induced arterial stiffening. Their responsiveness to TGF-β1/Smad3 signaling enables detailed investigation of adventitial fibrosis in aortic aneurysms, extracellular matrix (ECM) dysregulation, and inflammatory crosstalk in atherosclerosis. These cells are particularly valuable for screening of anti-fibrotic agents (e.g., pirfenidone) and mechanotransduction modulators targeting pathological stiffening. The model provides crucial insights bridging basic vascular biology with clinical therapeutic development.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).